Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival
byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Updated on: December 22,2023
15

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival
byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Updated on:December 22,2023
15
